SCHEMBL9563348

SCHEMBL9563348

Cc1ccc([N+](=O)[O-])c(OCCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.61
KDM4E B2RXH2 5/20 0.61
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
MAPT P10636 1/20 0.58
LMNA P02545 1/20 0.54
BCHE P06276 5/20 0.54
TP53 P04637 1/20 0.52
PARP14 Q460N5 1/20 0.51
CYP2D6 P10635 2/20 0.50
CYP2C19 P33261 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
CYP1A2 P05177 1/20 0.47
PKM P14618 1/20 0.46
OPRM1 P35372 1/20 0.46
OPRL1 P41146 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9563252 0.93 ALDH1A1 (0.59) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL9563337 0.91 KDM4E (0.57) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL9563399 0.90 KDM4E (0.55) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL9563236 0.89 BCHE (0.55) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL9563333 0.88 CYP2D6 (0.60) ALDH1A1KDM4EBCHEPARP14CYP2D6
SCHEMBL9563238 0.85 CYP2D6 (0.65) ALDH1A1KDM4ELMNABCHEPARP14
SCHEMBL9563349 0.84 CYP2D6 (0.64) ALDH1A1KDM4ELMNABCHEPARP14
SCHEMBL9563379 0.83 CYP2D6 (0.55) ALDH1A1KDM4EKMT2AMAPTBCHE
SCHEMBL9563284 0.83 CYP2D6 (0.55) ALDH1A1KDM4ELMNABCHEPARP14
SCHEMBL9563223 0.83 PARP14 (0.52) LMNABCHEPARP14CYP2D6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0529365-A1 Diarylmethoxypiperidine derivatives Kaken Pharmaceutical Co., Ltd. (JP) 1993-03-03 EP disclosed
US-5190959-A Antihistamines, antiallergens, treatment of ischemic heart disease KAKEN PHARMACEUTICAL CO. LTD. (JP) 1993-03-02 US disclosed